Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Estradiol cypionate |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Free estradiol |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol hemihydrate (substance) |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
17 beta-estradiol |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol benzoate |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oestradiol measurement |
Has measured component |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum estradiol measurement |
Has measured component |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plasma estradiol measurement |
Has measured component |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotropin stimulation panel, estradiol response |
Component |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oestradiol measurement |
Component |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum estradiol measurement |
Component |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Plasma estradiol measurement |
Component |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quinestrol preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
17 beta-estradiol preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mestranol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing quinestrol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oestradiol adverse reaction |
Causative agent (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oral estradiol adverse reaction |
Causative agent (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol implant adverse reaction |
Causative agent (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Topical oestradiol adverse reaction |
Causative agent (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to estradiol |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral estradiol allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol implant allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical estradiol allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol [endocrine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 10 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 20 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 80micrograms patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 1.25g/dose gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 37.5micrograms patch (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 40micrograms patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.5mg/dose gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 1mg/dose gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 25mcg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 75micrograms patch (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 25micrograms patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 50micrograms patch (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 100micrograms patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 50 mg prolonged-release subcutaneous implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 100mg implant (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
More estradiol 1 |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 600 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol [gynae] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol [malignancy] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral oestradiol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing estradiol in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 2mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 2.0mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estrone 2 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05 mg/day |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 5.75mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol 100 microgram/1 milliliter conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 3.9mg/patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/24 hr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estrone 15 mg/mL suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 2.17mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.585mg patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.78mg patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 1.17mg patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 1.56mg patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 10.3mg patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.0375mg/day |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/day |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.075mg/day |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.1mg/day |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.025mg/day patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 20mg patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.0375mg/day patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/day patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.075mg/day patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.1mg/day patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol 50micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol 0.02mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 5.85mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.025mg/unt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol + estradiol + norgestimate 1mg/1mg/0.09mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol + norethindrone acetate 0.62mg/2.7mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oestradiol + norethindrone acetate 1mg/0.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol + levonorgestrel 0.03mg/0.15mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 40 microgram and levonorgestrel 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl oestradiol + levonorgestrel 0.05mg/0.25mg pills |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only ethinyl estradiol 0.035 mg and norethisterone 0.5 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|